(Total Views: 641)
Posted On: 04/04/2025 8:10:33 PM
Post# of 154635
Penicillin & Leronlimab:
From Science direct:
In the United States, it has been estimated that 500 to 1000 deaths per year are secondary to penicillin-induced anaphylaxis
Google:
Anaphylaxis is a severe, potentially life-threatening allergic reaction that can develop rapidly.
It is also known as anaphylactic shock.
Google:
In 2022, there were approximately 53.2 million penicillin prescriptions in the United States, translating to a rate of 159 prescriptions per 1,000 people.
Google:
A study published in the National Institutes of Health (NIH) found that animals were infused intravenously with two mAbs at 25 mg/kg each, either leronlimab-PLS (Group 1) or leronlimab-WT (Group 2); both groups received the control anti-DSP mAb.
According to the National Institutes of Health (NIH) (.gov) animals were pre-treated with a control anti-DSP mAb to reduce the risk of anaphylactic reactions.
That is from our FcRn abstract under:
Selection of the control rhesus anti-desipramine mAb:
To account for the intrinsic differences between individual animals both within and between the groups, we co-administered the rhesus anti-desipramine (DSP) mAb, denoted ‘control mAb’, at the same time as the therapeutic leronlimab mAbs.
We have built-in anti an deadly side effects trigger, that Penicillin can cause. Of course we're not going to compete with aspirin or Penicillin, just looking at death rates per say while we wait.
So we have the 2 drugs that are known as super safe, can trigger deaths, & to the other extreme of :
Leronlimab treating Hiv & the most aggressive of deadly cancers, with so far 1600 patients across wide range of different disease trials, & no reported deaths.
What a surprise.....wow!!
From Science direct:
In the United States, it has been estimated that 500 to 1000 deaths per year are secondary to penicillin-induced anaphylaxis
Google:
Anaphylaxis is a severe, potentially life-threatening allergic reaction that can develop rapidly.
It is also known as anaphylactic shock.
Google:
In 2022, there were approximately 53.2 million penicillin prescriptions in the United States, translating to a rate of 159 prescriptions per 1,000 people.
Google:
A study published in the National Institutes of Health (NIH) found that animals were infused intravenously with two mAbs at 25 mg/kg each, either leronlimab-PLS (Group 1) or leronlimab-WT (Group 2); both groups received the control anti-DSP mAb.
According to the National Institutes of Health (NIH) (.gov) animals were pre-treated with a control anti-DSP mAb to reduce the risk of anaphylactic reactions.
That is from our FcRn abstract under:
Selection of the control rhesus anti-desipramine mAb:
To account for the intrinsic differences between individual animals both within and between the groups, we co-administered the rhesus anti-desipramine (DSP) mAb, denoted ‘control mAb’, at the same time as the therapeutic leronlimab mAbs.
We have built-in anti an deadly side effects trigger, that Penicillin can cause. Of course we're not going to compete with aspirin or Penicillin, just looking at death rates per say while we wait.
So we have the 2 drugs that are known as super safe, can trigger deaths, & to the other extreme of :
Leronlimab treating Hiv & the most aggressive of deadly cancers, with so far 1600 patients across wide range of different disease trials, & no reported deaths.
What a surprise.....wow!!
(2)
(0)
